Approaching GOIS - Thirteenth Session

Approaching GOIS - Thirteenth Session

by Site Admin -
Number of replies: 0

 a

                Global Oncology University ( GO-U)

Approaching “Global Oncology-Implementing Science” GOIS courses    

13th session Wednesday January 24, 2024 , at 4.00-5.30 pm GMT

---------------------------------  

-An Introduction to: African Access Initiative AAI  

(An initiative of Bio Venture for Global Health: BVGH)

By: Jennifer Dent & Katy Graef

----------------------------------

.  Examples of scientific explorations for resource-saving better-value cancer drug systemic therapy, 

Part 7of 7 of the series

By: Prof. Ahmed Elzawawy,    

----------------------------------- 

- Comments and suggestions &  Q & A

Plus sending questions, comments and suggestions via e-mails & web  

All your feedback and comments will be directed to the distinguished experts and co-leaders of GOIS

==================================  

Distinguished Faculty presentation of the 13th Session: 

a

Jennifer Dent:  is the President & CEO of BIO Ventures for Global Health. She joined BVGH in 2011 and took over leadership of the organization in 2012. Leveraging her international industry experience, Jennifer has facilitated numerous partnerships across the private, government, and public sectors to tackle tough global health challenges utilizing a market-driven approach. 

==================================

a

 Katy Graef is Vice President, Programs at BIO Ventures for Global Health (BVGH). She is responsible for developing new program strategies and leading BVGH’s program to improve cancer patient outcomes in Africa, the African Access Initiative.

 

 Distinguished Scientific Experts of the 13th session:          

 a 

Prof. Eduardo L. Cazap  MD, PhD, FASCO, Argentina , President & Founder -Latin-American & Caribbean Society of Medical Oncology (SLACOM) Co-Chair, Network of Latin American Cancer Institutes (RINC) .Past President - Union for International Cancer Control (UICC)

==================================

 

a

Professor David Kerr CBE MD PhD DSc FRCP FRCGP FACP FESMO FMedSci , UK : David contributes to Oxford as Professor of Cancer Medicine, where he has worked with colleagues to build a new Institute for Cancer Medicine and Cancer Hospital.  Co-Leader, The win-win initiative and Co-Director, Global Oncology-Implementing Science Courses and program, Co-founder, GO-U.  ==================================

a

Professor Karol Sikora, MA, MB BChir, PhD, MD, FRCR, FRCP, FFPM,  UK , Consultant Oncologist, is the Medical Director of Cancer Partners International. He was the Founding Dean and now Professor of Medicine at Britain’s first independent Medical School at the University of Buckingham and a Fellow of Corpus Christi College, Cambridge. He was Professor and Chairman of the Department of Cancer Medicine at Imperial College School of Medicine and is still honorary Consultant Oncologist at Hammersmith Hospital, London.  He was seconded to be Director of the WHO Cancer Programme in 2000. Co-Leader, The win-win initiative and Co-Director, Global Oncology-Implementing Science Courses and program, Co-founder, GO-U. 

==================================

a

Prof. Ahmed Elzawawy, MD, PhD, Founding Chair, win-win Scientific initiative & Co-founder & Chair, Board of Directors, GO-U & Global Oncology-Implementing Science Courses and program & Founding President, ICEDOC & Past President, AORTIC & Prof. Clinical Oncology, Suez Canal University &Chair. Clinical and Radiation Oncology Center , Port Said, Egypt.    

==================================

 

a

Prof. Wilfred Ngwa, PhD, Dana-Farber/Harvard Cancer Center, University of Massachusetts Lowell, and Johns Hopkins University, USA. He is a distinguished professor of global public health, and distinguished professor of public health. He is founding Director of the Global Health Catalyst launched at the Harvard Radcliffe Institute in 2015 He currently chairs the Africa Health and Infrastructure Committee advising the USA government on Global Health.  He is a co-founder (with Prof Ahmed Elzawawy and distinguished faculty) of Global Oncology University.  Founder Director, GHC& Co-founder, GO-U.  Co-Leader, The win-win initiative and Co-Director, Global Oncology-Implementing Science Courses and program, GO-U

==================================

a

 Prof Cristina Stefan is a professor in medicine and global health, currently the President and CEO of the Medical Education Research and Innovation, adjunct professor at SingHealth Duke NUS  Singapore and UMF University, Main, USA. PhD in medical education, MBA , France, MSc , Pediatrics and Oncology , South Africa, MSc cancer epidemiology , UK.

She was past President , AORTIC , She was voted as the most influential African woman in business and government (medicine) in 2016 , among the top 100 Women Leaders in Healthcare in Asia, in 2020. In 2022, she received IARC the (International Agency for Research in Cancer) award for women in cancer research.

A  co-leader and distinguished faculty , The Global Oncology-implementing Science Program ( GOIS)

==================================

 a

Prof. Twalib A. Ngoma  , Prof. Clinical Oncology ,  Research Chair Holder Muhimbili University of Health and Allied Sciences  MUHAS ,  Dar es Salaam, Tanzania. Co-Leader, The win-win initiative and Co-Founder, Global Oncology University GO-U    

================================== 

 

a

-        Dr. Mrs. Beatrice Wiafe Addai, MD, PhD,
Consultant Breast Surgeon, C.E.O., Peace and Love Hospitals, Ghana
President and Founder, Breast Care International, Fmr Member, Ethics committee - IARC, Chairperson, Ghana Cancer Board, Medical Advisory Board Member, Direct Relief, Member, UICC.   

==================================

An Acknowledgment to Dr. Fifi M. Elsayed , MD , Clinical Oncologist, Department of Clinical Oncology and Nuclear Medicine ,  Suez Canal University , Ismailia, Egypt , for contribution in preparing the lecture

==================================

Further reading:

1. “ Approaching Global Oncology. The win-win model”

 https://iopscience.iop.org/book/978-0-7503-3075-6   The first book summary (in front Matter) and the first chapter are free online.  

& This session is based on Chapters 14, 15 , 23 , 24 

& The next series of sessions is based on Chapters 14-24 & 35-36

2.  The Win-Win Initiative.  www.icedoc.org/winwin.htm   and www.icedoc.net/winwin.htm  

 3. Elzawawy A. (2012). Science and Affordability of Cancer Drugs and Radiotherapy in the World - Win-Win Scenarios.  In: Advances in Cancer Management, Ravinder Mohan (Ed.), InTech, Free access and download:  https://www.intechopen.com/chapters/26808

 ======================

-How to join all sessions (It is for all GOIS sessions): please , Click on  & register and Login in , Create an account –if you haven’t-  fill the form, submit, you’ll receive an e-mail

https://icedoc.website/cms/mod/zoom/view.php?id=30

  ……………………………………..

- Or: Direct Zoom to this 13th session, on Wednesday 24th January,2024  at 4 .00 PM ,  GMT , Click on five minutes before the session:  Join Zoom Meeting  

https://us06web.zoom.us/j/89269248817?pwd=DR8aP2ScYJ0W8fG4PFoGNG1LkXNQPR.1